arrow_back Civic Audit
Share share

New rules for former health officials: limits on vaccine company roles and patents

New rules aim to prevent conflicts of interest for former high-ranking health agency officials. They restrict their ability to work for vaccine companies and to own patents on medicines and vaccines, intending to boost public trust in health decisions.
Key points
Former top officials from health agencies (NIH, FDA, CDC) will be prohibited from serving on boards of entities involved in vaccine development or research.
Top federal officials will not be allowed to own or profit from patents for vaccines or medical treatments, regardless of when the patent was obtained.
These provisions aim to increase transparency and prevent situations where personal interests could influence public health decisions.
article Official text account_balance Process page notifications_active Track this Bill
Status: Expired
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_9708
Sponsor: Rep. Gohmert, Louie [R-TX-1]
Process start date: 2023-01-03
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Fixing Administrations Unethical Corrupt Influence Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_9708.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-01-03.

What are the main provisions?

Key points include:

  • Former top officials from health agencies (NIH, FDA, CDC) will be prohibited from serving on boards of entities involved in vaccine development or research.
  • Top federal officials will not be allowed to own or profit from patents for vaccines or medical treatments, regardless of when the patent was obtained.
  • These provisions aim to increase transparency and prevent situations where personal interests could influence public health decisions.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Gohmert, Louie [R-TX-1].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on the Judiciary.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Courts and Law